PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.75M | -7.35M | -7.56M | -9.01M | -9.43M |
| Total Depreciation and Amortization | 15.10K | 15.10K | 15.10K | 15.10K | 15.10K |
| Total Amortization of Deferred Charges | 265.50K | 448.80K | 474.40K | -307.20K | 1.11M |
| Total Other Non-Cash Items | 3.79M | 1.16M | 1.61M | 2.00M | 448.00K |
| Change in Net Operating Assets | 2.89M | 1.36M | 1.76M | 1.39M | -1.24M |
| Cash from Operations | -2.79M | -4.37M | -3.70M | -5.92M | -9.10M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4.32M | -- | -1.07M | 0.00 | 19.24M |
| Total Debt Repaid | -18.75M | -1.51M | -1.87M | -1.02M | -19.70M |
| Issuance of Common Stock | 97.20K | 833.40K | 3.97M | 1.26M | 1.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.05M | -- | 3.19M | 0.00 | 0.00 |
| Cash from Financing | -13.27M | -679.80K | 4.22M | 241.20K | 995.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.06M | -5.05M | 513.30K | -5.67M | -8.11M |